How can we prevent viral reactivation in liver transplantation from donors with latent hepatitis B virus infection?

Journal of Gastroenterology

Volumn 36, Issue 3, 2001, Pages 212-213

  Marusawa, H ^a   Chiba, T ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIRCULAR DNA; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; VIRUS DNA;

ANTIGEN DETECTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA DETERMINATION; DNA STRUCTURE; EDITORIAL; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; INFECTION RISK; LATENT VIRUS INFECTION; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT; SCREENING TEST; SERODIAGNOSIS; STRUCTURE ANALYSIS; VIRUS CARRIER; VIRUS REACTIVATION; VIRUS TRANSMISSION;

GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION;

EID: 0035073923     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350170132     Document Type: Editorial

References (15)

1. Hepatitis B virus infection and liver transplantation
2. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations
3. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease
4. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living-related liver transplants
5. "Occult" hepatitis B virus as source of infection in liver transplant recipients
6. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors
7. Infectivity of hepatic allografts with antibodies to hepatitis B virus
8. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen
9. Reappearance of HBsAg with compartmentalized different HBV strains in allograft versus PBMC of the recipient
10. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen
11. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus
12. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen
13. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
14. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients
15. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation